You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Over the Horizon Underwater Communications

    SBC: Physical Devices, Inc.            Topic: SOCOM13002

    An analysis of alternatives, including modeling, will be conducted of such candidates technologies such as localization, energy provision, and reporting, which are required for long-duration, LPD localization of various types of vessels operating in blue, green and brown water, with near-real time communications, to support global maritime tag track and locate capabilities in support of national a ...

    SBIR Phase I 2013 Department of DefenseSpecial Operations Command
  2. Integrated Wideband Tactical Power Amplifier

    SBC: VADUM INC            Topic: SOCOM13004

    Vadum proposes a feasibility study to define the next generation power amplifier for the Special Operations Forces (SOF) warfighter. This program will deliver extended bandwidth, more complex waveform capability, longer battery life, higher field reliability, and wide compatibility across radio types. The Phase I deliverable will be a comprehensive trade study and a proposed PA design which incl ...

    SBIR Phase I 2013 Department of DefenseSpecial Operations Command
  3. Family of Sub-Sonic Ammunition

    SBC: Stillwood Ammunition Systems LLC.            Topic: SOCOM13005

    Technical abstract 13.1-005 Today there is no sub-sonic ammunition currently type classified for use in the calibers provided by any DoD Service. Although sub-sonic rounds exist for some calibers, these rounds are not cost effective and exhibit excessive deviations in velocity (affecting accuracy), incomplete chamber sealing, absence of clean propellant burn, and inability to cycle the action on ...

    SBIR Phase I 2013 Department of DefenseSpecial Operations Command
  4. Practical Roots of Trust for Mobile Devices

    SBC: GALOIS, INC.            Topic: HSB0132002

    To meet the critical security needs of the Department of Homeland Security and others, we propose two methods for providing a secure root of trust for mobile devices. One method is designed to integrate as easily into existing systems, while the other requires deeper integration but provides correspondingly stronger security. The keys to our work are practicality and integration: practicality to e ...

    SBIR Phase I 2013 Department of Homeland Security
  5. A Rapid-to-Deploy Agent-Based Wireless Sensing Architecture for Autonomous Structural Collapse Prediction

    SBC: CIVIONICS, LLC            Topic: HSB0132004

    While most media attention in the wake of a terrorist attack, a natural disaster, or even a single building fire focuses rightly on the safety and wellbeing of the general public, one often overlooked aspect of these catastrophic events is the extreme risk taken by first responders who enter structures on the verge of collapse. For example, after the attacks on the World Trade Center on September ...

    SBIR Phase I 2013 Department of Homeland Security
  6. Osteochondral tissue repair in an ovine model using a 3D woven poly (e-caprolacto

    SBC: Cytex Therapeutics, Inc.            Topic: NIA

    DESCRIPTION (provided by applicant): Standard microfracture is a first-line, widely used and cost-effective surgical technique for repairing damaged articular cartilage, but, it is limited by decreased long-term efficacy and limited applicability in largerlesions. This leads to a burgeoning economic burden associated with primary and follow-up treatment costs, estimated at more than 40 billion dol ...

    STTR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
  7. Controlling mechanical signal transduction to treat osteoarthritis

    SBC: Cytex Therapeutics, Inc.            Topic: NIA

    DESCRIPTION (provided by applicant): Controlling mechanical signal transduction to treat osteoarthritis Abstract The TRPV4 calcium (Ca++) permeable ion channel has been shown to be expressed and functional in chondrocytes, the cells responsible for the maintenance of cartilage in weight-bearing joints. Trauma of joints with subsequent damage of cartilage, as well as chronically increased joint loa ...

    STTR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
  8. Evaluation of a new class of molecules for treating MRSA infective endocarditis

    SBC: AGILE SCIENCES, INC.            Topic: NIAID

    DESCRIPTION (provided by applicant): Patients with infective endocarditis (IE) have a poor prognosis with one third of the patients succumbing to the infection within the first year. Treatments for endocarditis involve antibiotic therapy and/or surgery that cost upwards of 100,000 per patient; however, many cases do not respond to the antibiotic treatment and surgery poses high risks. Cases of en ...

    STTR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
  9. A Synthetic Human Cytomegalovirus Vaccine Platform

    SBC: TOMEGAVAX, INC.            Topic: NIAID

    DESCRIPTION (provided by applicant): The goal of this project is to synthesize, based on genomic sequence information, a human cytomegalovirus (HCMV) strain with demonstrated ability to establish persistent infection in sero-positive individuals. The resulting synthetic product will form the basis for the development of attenuated HCMV vaccines. Innovative synthetic biology methods will overcome ...

    STTR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
  10. Targeting c-Myc and Akt with PP2A reactivation therapy for the treatment of breas

    SBC: ONCOTIDE PHARMACEUTICALS, INC.            Topic: NCI

    DESCRIPTION (provided by applicant): Each year in the United States over 270,000 women will be diagnosed with breast cancer and over 40,000 will die from the disease. While multiple forms of breast cancer exist, a common theme in most of the forms involvesaberrations in signal transduction pathways that lead to inhibition of the programmed cell death process known as apoptosis. Apoptosis is a care ...

    STTR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government